Vertex Pharmaceuticals Inc
VRTX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $949.83M | $784.54M | $578.17M | $413.78M |
| Net Income | $57.52M | $128.75M | -$102.95M | -$38.84M |
| EPS Diluted | $0.22 |
Vertex Pharmaceuticals Inc · CIK 875320 · Engraved from SEC EDGAR
| $0.50 |
| -$0.41 |
| -$0.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.